US EditionPublished • loading... • Updated
ATB Therapeutics: Antibody Seeker Missiles for Cancer and Autoimmune Diseases
Summary by BioVox
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
ATB Therapeutics: Antibody Seeker Missiles for Cancer and Autoimmune Diseases
Header Image: Bertrand Magy (left) and Max Houry (right), Co-founders of ATB Therapeutics.When people in the future look back at 21st-century medicine, chemotherapies may strike them as archaic. These therapies use powerful chemicals to kill fast-growing cells in your body. They remain some of our best solutions for killing cancer cells but come at a steep cost to patients. People often experience harsh side effects — like nausea and hair loss —…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
